Cargando…

688. Risk of Clostridioides difficile Infection and Antibiotic Associated Diarrhea in Patients Receiving Outpatient Parenteral Antimicrobial Therapy

BACKGROUND: The colonic microbiome plays a critical role in resisting the ingrowth of pathogenic microbes like Clostridioides difficile (C. difficile). Disruption of the microbiome by antibiotics is known to cause antibiotic-associated diarrhea (AAD) and C. difficile infection (CDI). Outpatient pare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaramillo, Mario, Musmar, Ahmad S, Shi, Aishan, Al Momani, Shaden, Alexander Perry, D, Zangeneh, Tirdad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679206/ http://dx.doi.org/10.1093/ofid/ofad500.750

Ejemplares similares

Diarrhea or No Diarrhea, It Still Hurts: An Atypical Case of Clostridioides difficile
por: Singla, Abhinav, et al.
Publicado: (2020)

Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea
por: Hernández, Marta, et al.
Publicado: (2019)

688. In Vitro Activity of Eravacycline, a New Tetracycline Analog, and Comparators Against the Six Most Commonly Isolated Ribotypes of Clostridioides difficile
por: Basseres, Eugenie, et al.
Publicado: (2019)

Antibiotic associated diarrhea due to Clostridioides difficile in a tertiary care teaching hospital, central India
por: Kapoor, Sunandini, et al.
Publicado: (2023)

Comparing Injecting Drug Users with Others Receiving Outpatient Parenteral Antibiotic Therapy
por: Dobson, Pauline M, et al.
Publicado: (2017)

Rate of broad-spectrum antibiotic overuse in patients receiving outpatient parenteral antibiotic therapy (OPAT)
por: Brenon, Jessa R., et al.
Publicado: (2021)

950. Impact of the COVID 19 pandemic on antimicrobial stewardship program, broad-spectrum antibiotics consumption and Clostridioides difficile diarrhea incidence
por: Ferreiro, Jose Luis Lamas, et al.
Publicado: (2022)

Frontiers in antibiotic alternatives for Clostridioides difficile infection
por: Phanchana, Matthew, et al.
Publicado: (2021)

Characteristics of Faecal Microbiota in Korean Patients with Clostridioides difficile-associated Diarrhea
por: Jeon, Yong Duk, et al.
Publicado: (2019)

Risk Factors of Patients With Diarrhea for Having Clostridioides (Clostridium) difficile Infection
por: Lang, Vanessa, et al.
Publicado: (2022)

Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics
por: van Werkhoven, Cornelis H., et al.
Publicado: (2021)

115. The Utility of (1→3)-β-D-glucan Assay in the Diagnosis of Severe Coccidioidomycosis Infections among Immunocompromised Hosts
por: Ayazi, Parham, et al.
Publicado: (2021)

Microbiota in Clostridioides difficile-Associated Diarrhea: Comparison in Recurrent and Non-Recurrent Infections
por: Gazzola, Alessandra, et al.
Publicado: (2020)

Clostridioides difficile infection in dogs with chronic-recurring diarrhea responsive to dietary changes
por: Silva, Rodrigo Otávio Silveira, et al.
Publicado: (2018)

Prevalence of Clostridioides difficile Infection in Critically Ill Patients with Extreme Leukocytosis and Diarrhea
por: Teja, Bijan, et al.
Publicado: (2021)

Antibiotic Resistance and Biofilm Production Capacity in Clostridioides difficile
por: Rahmoun, Layan Abu, et al.
Publicado: (2021)

Clostridium difficile and Antibiotic-associated Diarrhea
por: Bhattacharyya, Mahuya, et al.
Publicado: (2020)

Lactulose may reduce Clostridium difficile‐related diarrhea among patients receiving antibiotics
por: Maltz, Charles, et al.
Publicado: (2020)

Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients
por: Vázquez-Cuesta, Silvia, et al.
Publicado: (2023)

Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action
por: Dysangco, Andrew T., et al.
Publicado: (2022)

1758. Retrospective cohort analysis of outcomes in patients receiving outpatient parenteral antibiotic therapy (OPAT)
por: Billmeyer, Kaylyn, et al.
Publicado: (2022)

An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy
por: Bradley, Abby C., et al.
Publicado: (2023)

The Utility of (1→3)-β-D-Glucan Testing in the Diagnosis of Coccidioidomycosis in Hospitalized Immunocompromised Patients
por: Al-Obaidi, Mohanad M., et al.
Publicado: (2022)

109. Differences in Gram-Negative Antibiotic Susceptibility Among Patients Receiving Fecal Microbiota Transplant for Clostridioides difficile
por: Woodworth, Michael, et al.
Publicado: (2018)

2406. Trends of Clostridioides difficile-Associated Diarrhea at a Tertiary Care Center in India
por: Khullar, Swati, et al.
Publicado: (2019)

782. Clostridioides difficile environmental contamination in hospitalized patients with diarrhea: a pilot study
por: Warren, Bobby G, et al.
Publicado: (2020)

The Impact of Infection Versus Colonization on Clostridioides difficile Environmental Contamination in Hospitalized Patients With Diarrhea
por: Warren, Bobby G, et al.
Publicado: (2022)

Clostridioides difficile Diarrhea: An Emerging Problem in a South Indian Tertiary Care Hospital
por: Kannambath, Rachana, et al.
Publicado: (2021)

Modeling inpatient and outpatient antibiotic stewardship interventions to reduce the burden of Clostridioides difficile infection in a regional healthcare network
por: Rhea, Sarah, et al.
Publicado: (2020)

Retrospective Cohort Analysis of Outpatient Antibiotic Use for Clostridioides difficile-Indicated Agents in British Columbia, from 2000 to 2018
por: Saatchi, Ariana, et al.
Publicado: (2023)

The microbial diversity following antibiotic treatment of Clostridioides difficile infection
por: Binyamin, Dana, et al.
Publicado: (2021)

Antibiotic resistance and genomic features of Clostridioides difficile in southwest China
por: Gu, Wenpeng, et al.
Publicado: (2022)

381. Antibiotic Spectrum Index and Risk of Clostridioides difficile Infection
por: Ray, Michael J, et al.
Publicado: (2022)

Influence of Probiotics on the Development of Clostridioides difficile Infection in Patients Receiving Fluoroquinolones
por: Sheffield, Mary E., et al.
Publicado: (2021)

Clostridioides difficile infection in cancer patients receiving immune checkpoint inhibitors
por: Vasavada, Shaleen, et al.
Publicado: (2022)

745 Risk of Peripheral Blood Eosinophilia and Hypersensitivity Reactions among Patients Receiving Outpatient Parenteral Antibiotics
por: Blumenthal, Kimberly, et al.
Publicado: (2014)

Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections
por: Bork, Jacqueline T., et al.
Publicado: (2019)

351. Factors Predicting Readmission within 90 days in Patients Receiving Outpatient Parenteral Antibiotic Therapy
por: Smola, Kyle, et al.
Publicado: (2023)

98. Outcomes of Clinical Decision Support for Outpatient Management of Clostridioides difficile Infection
por: Wu, Tiffany, et al.
Publicado: (2021)

Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis
por: Tu, Jacky, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_urgs13unin0fv1t60e001dcjs0